Your search returned 5 results.

Sort
Results
1.
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. MedStar authors:
  • Garcia-Garcia, Hector M
  • Waksman, Ron
PMID:
  • 36137689
Year: 2022
Citation:
  • Jacc: Cardiovascular Interventions. 15(18):1852-1860, 2022 Sep 26.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
2.
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial. MedStar authors:
  • Garcia-Garcia, Hector M
  • Waksman, Ron
PMID:
  • 32499026
Year: 2020
Citation:
  • Jacc: Cardiovascular Interventions. 13(11):1343-1353, 2020 06 08.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
3.
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. MedStar authors:
  • Garcia-Garcia, Hector M
  • Waksman, Ron
PMID:
  • 30354631
Year: 2018
Citation:
  • Circulation: Cardiovascular Interventions. 11(10):e007331, 2018 Oct.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bennett J, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Marcusohn E, Massaro JM, Roguin A, Waksman R
4.
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors:
  • Garcia-Garcia, Hector M
  • Waksman, Ron
PMID:
  • 28851504
Year: 2017
Citation:
  • Lancet. 390(10105):1843-1852, 2017 Oct 21.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R
5.
Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stents. MedStar authors:
  • Kitabata, Hironori
  • Laynez-Carnicero, Ana
  • Loh, Joshua P
  • Pichard, Augusto D
  • Sardi, Gabriel L
  • Satler, Lowell F
  • Torguson, Rebecca
  • Waksman, Ron
  • Xue, Zhenyi
PMID:
  • 24684759
Year: 2014
Citation:
  • Cardiovascular Revascularization Medicine. 15(2):86-91, 2014 Mar.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Comparative Study
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Kitabata H, Laynez-Carnicero A, Loh JP, Pichard AD, Sardi GL, Satler LF, Torguson R, Waksman R, Xue Z
Pages

Powered by Koha